T4AM.HCl,Phenol, 4-[4-(2-aMinoethyl)-2,6-diiodophenoxy]-2,6-diiodo-, hydrochloride (1:1)
- $170 - $1325
- Product name: T4AM.HCl,Phenol, 4-[4-(2-aMinoethyl)-2,6-diiodophenoxy]-2,6-diiodo-, hydrochloride (1:1)
- CAS: 788824-71-5
- MF: C14H12ClI4NO2
- MW: 769.32
- EINECS:-0
- MDL Number:
- Synonyms:T4AM.HCl,Phenol, 4-[4-(2-aMinoethyl)-2,6-diiodophenoxy]-2,6-diiodo-, hydrochloride (1:1);3,3',5,5'-Tetraiodothyronamine Hydrochloride;4-[4-(2-aMinoethyl)-2,6-diiodophenoxy]-2,6-diiodo-, hydrochloride
3 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 2.5mg
- 25mg
- ManufacturerMedical Isotopes, Inc.
- Product number99458
- Product description3,3?,5,5?-TetraiodothyronamineHydrochloride
- Packaging2.5mg
- Price$475
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT296180
- Product description3,3'',5,5''-TetraiodothyronamineHydrochloride
- Packaging2.5mg
- Price$170
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT296180
- Product description3,3'',5,5''-TetraiodothyronamineHydrochloride
- Packaging25mg
- Price$1325
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 99458 | 3,3?,5,5?-TetraiodothyronamineHydrochloride | 2.5mg | $475 | 2021-12-16 | Buy |
TRC | T296180 | 3,3'',5,5''-TetraiodothyronamineHydrochloride | 2.5mg | $170 | 2021-12-16 | Buy |
TRC | T296180 | 3,3'',5,5''-TetraiodothyronamineHydrochloride | 25mg | $1325 | 2021-12-16 | Buy |
Properties
Melting point :>250°C (dec.)
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :DMSO (Sllightly), Methanol (Slightly)
form :Solid
color :Off-White to Pale Brown
Stability :Hygroscopic
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :DMSO (Sllightly), Methanol (Slightly)
form :Solid
color :Off-White to Pale Brown
Stability :Hygroscopic
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|